GH1 and metabolic dysfunction-associated steatotic liver disease: The current study deepens our understanding of the biologic effects of GH axis augmentation among PLWH with NAFLD and introduces innovative potential therapeutic targets and protein signatures of treatment response that warrant further investigation.